Epigenetic control of the foxp3 locus in regulatory T cells
- PMID: 17298177
- PMCID: PMC1783672
- DOI: 10.1371/journal.pbio.0050038
Epigenetic control of the foxp3 locus in regulatory T cells
Abstract
Compelling evidence suggests that the transcription factor Foxp3 acts as a master switch governing the development and function of CD4(+) regulatory T cells (Tregs). However, whether transcriptional control of Foxp3 expression itself contributes to the development of a stable Treg lineage has thus far not been investigated. We here identified an evolutionarily conserved region within the foxp3 locus upstream of exon-1 possessing transcriptional activity. Bisulphite sequencing and chromatin immunoprecipitation revealed complete demethylation of CpG motifs as well as histone modifications within the conserved region in ex vivo isolated Foxp3(+)CD25(+)CD4(+) Tregs, but not in naïve CD25(-)CD4(+) T cells. Partial DNA demethylation is already found within developing Foxp3(+) thymocytes; however, Tregs induced by TGF-beta in vitro display only incomplete demethylation despite high Foxp3 expression. In contrast to natural Tregs, these TGF-beta-induced Foxp3(+) Tregs lose both Foxp3 expression and suppressive activity upon restimulation in the absence of TGF-beta. Our data suggest that expression of Foxp3 must be stabilized by epigenetic modification to allow the development of a permanent suppressor cell lineage, a finding of significant importance for therapeutic applications involving induction or transfer of Tregs and for the understanding of long-term cell lineage decisions.
Conflict of interest statement
Competing interests. We herewith state a competing financial interest for the authors S. Olek and U. Baron, who are a founder and an employee of the company Epiontis, respectively.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1796932/bin/pbio.0050038.g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1796932/bin/pbio.0050038.g002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1796932/bin/pbio.0050038.g003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1796932/bin/pbio.0050038.g004.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1796932/bin/pbio.0050038.g005.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1796932/bin/pbio.0050038.g006.gif)
![Figure 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1796932/bin/pbio.0050038.g007.gif)
Similar articles
-
Induction and maintenance of regulatory T cells by transcription factors and epigenetic modifications.J Autoimmun. 2017 Sep;83:113-121. doi: 10.1016/j.jaut.2017.07.002. Epub 2017 Jul 11. J Autoimmun. 2017. PMID: 28709726 Review.
-
Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus.J Immunol. 2013 Apr 1;190(7):3180-8. doi: 10.4049/jimmunol.1203473. Epub 2013 Feb 18. J Immunol. 2013. PMID: 23420886
-
Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice.J Mol Med (Berl). 2009 Dec;87(12):1191-205. doi: 10.1007/s00109-009-0530-8. Epub 2009 Oct 20. J Mol Med (Berl). 2009. PMID: 19841877
-
Epigenetic mechanisms of regulation of Foxp3 expression.Blood. 2009 Oct 29;114(18):3727-35. doi: 10.1182/blood-2009-05-219584. Epub 2009 Jul 29. Blood. 2009. PMID: 19641188 Free PMC article. Review.
-
DNA methylation controls Foxp3 gene expression.Eur J Immunol. 2008 Jun;38(6):1654-63. doi: 10.1002/eji.200838105. Eur J Immunol. 2008. PMID: 18493985
Cited by
-
Inferring upstream regulatory genes of FOXP3 in human regulatory T cells from time-series transcriptomic data.NPJ Syst Biol Appl. 2024 May 29;10(1):59. doi: 10.1038/s41540-024-00387-9. NPJ Syst Biol Appl. 2024. PMID: 38811598 Free PMC article.
-
Targeted Therapy of Multiple Sclerosis: A Case for Antigen-Specific Tregs.Cells. 2024 May 8;13(10):797. doi: 10.3390/cells13100797. Cells. 2024. PMID: 38786021 Free PMC article. Review.
-
Foxp3 depends on Ikaros for control of regulatory T cell gene expression and function.Elife. 2024 Apr 24;12:RP91392. doi: 10.7554/eLife.91392. Elife. 2024. PMID: 38655862 Free PMC article.
-
Regulatory T Cells for Control of Autoimmunity.Adv Exp Med Biol. 2024;1444:67-82. doi: 10.1007/978-981-99-9781-7_5. Adv Exp Med Biol. 2024. PMID: 38467973
-
The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases.Nat Rev Immunol. 2024 Jul;24(7):503-517. doi: 10.1038/s41577-024-00994-x. Epub 2024 Feb 19. Nat Rev Immunol. 2024. PMID: 38374298 Free PMC article. Review.
References
-
- Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531–562. - PubMed
-
- Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol. 2005;6:331–337. - PubMed
-
- Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27:20–21. - PubMed
-
- Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330–336. - PubMed
-
- Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–1061. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials